Infant Formula Marketing: Lessons From Recent Litigation

Robert J. Boyle, Gerard Hastings

Open source

DOI
10.1111/cea.70433
Published
2026-09-23
Container
Clinical & Experimental Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cea.70433,
  title = {Infant Formula Marketing: Lessons From Recent Litigation},
  author = {Robert J. Boyle and Gerard Hastings},
  year = {2026},
  journal = {Clinical \& Experimental Allergy},
  doi = {10.1111/cea.70433},
  url = {https://doi.org/10.1111/cea.70433}
}

RIS

TY  - JOUR
TI  - Infant Formula Marketing: Lessons From Recent Litigation
AU  - Robert J. Boyle
AU  - Gerard Hastings
PY  - 2026
JO  - Clinical & Experimental Allergy
DO  - 10.1111/cea.70433
UR  - https://doi.org/10.1111/cea.70433
ER  - 

APA

Boyle, R. J., & Hastings, G. (2026). Infant Formula Marketing: Lessons From Recent Litigation. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70433

Source records